The cautions are the ones already covered
BPC-157's studied effects center on angiogenesis, growth factor expression, and nitric oxide modulation, while TB-500's studied effects center on actin regulation, cell migration, and anti-inflammatory signaling
Here's all you need to know about it (and why it might become 2026's blockbuster drug): Current GLP-1 drugs can cause 35-40% of weight lost to be lean muscle, often worsened by inadequate protein and resistance training
It does, however, mark one of the largest efforts so far to test a GLP-1 medication against alcohol addiction in a controlled clinical setting
With the potential change in coverage, the out-of-pocket costs can be $12,000 a year or more to take these medications
The body takes it in more easily this way